AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

“These results demonstrate that it is possible to detect circulating tumor DNA more than three years prior to clinical ...

Don’t smoke: Smokers are more likely to develop diseases of the eyes that lead to vision loss, including AMD, glaucoma, and ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA—leaving them both at greater risk ...

Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

A father-of-three who was initially told his rib and back pain was likely caused by a pulled muscle was left in “complete ...